Teleflex Incorporated (TFX) Presents at Jefferies Global Healthcare Conference 2026 TranscriptSeeking Alpha • Wednesday
Teleflex: The Market Is Pricing The Transition, Not The Company Coming Out Of ItSeeking Alpha • 11/13/26
Teleflex (TFX) Q3 Earnings: Taking a Look at Key Metrics Versus EstimatesZacks Investment Research • 11/05/26
Teleflex Announces FDA Breakthrough Device Designation for Freesolve™ Resorbable Magnesium ScaffoldBusiness Wire • 10/22/26
Enrollment Completed in BIOMAG™-LL Clinical Study Evaluating Longer Lengths for Freesolve™ Resorbable Magnesium ScaffoldBusiness Wire • 10/12/26
Teleflex Announces Latest Peer-Reviewed Study Demonstrates a Significant Reduction in CLABSI Risk with Arrowg+ard™ TechnologyBusiness Wire • 09/29/26
Teleflex Appoints Veteran Medical Technology Executive Sean M. Salmon to Teleflex Board of DirectorsBusiness Wire • 09/08/26
Teleflex Features Innovative Dynetic™-35 Balloon-Expandable Cobalt Chromium Stent System at CIRSE 2026Business Wire • 09/04/26
Is TFX a Buy Now as Valuation Improves but Execution Risks Remain?Zacks Investment Research • 08/25/26
Can Teleflex's OEM Sale and Higher EPS Outlook Reshape 2026 Returns?Zacks Investment Research • 08/24/26